Chemours (CC) Stock Price
Chemours Price
Revenue at Chemours has contracted by 2.2% per year over the past 14 years to 5.81 B USD. Earnings per share have declined at 12.0% per year over the last 11 years. Chemours's net margin stands at -6.6%, down from 9.6% several years earlier. Chemours currently offers a dividend yield of about 3.34%. Analysts set a median price target of 18.36 USD, implying 19.6% above the current price. Of 18 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 46% above its 52-week low.
Chemours stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Chemours over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Chemours stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Chemours's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Chemours Price |
|---|---|
| 8/24/2026 | 15.35 USD |
| 8/21/2026 | 15.97 USD |
| 8/20/2026 | 15.69 USD |
| 8/19/2026 | 16.24 USD |
| 8/18/2026 | 15.25 USD |
| 8/14/2026 | 15.85 USD |
| 8/13/2026 | 15.26 USD |
| 8/12/2026 | 15.13 USD |
| 8/10/2026 | 14.79 USD |
| 8/7/2026 | 15.75 USD |
| 8/6/2026 | 15.11 USD |
| 8/5/2026 | 14.78 USD |
| 8/4/2026 | 17.57 USD |
| 8/3/2026 | 17.11 USD |
| 7/31/2026 | 16.61 USD |
| 7/30/2026 | 17.11 USD |
| 7/29/2026 | 16.39 USD |
| 7/27/2026 | 16.89 USD |
| 7/23/2026 | 17.47 USD |
| 7/22/2026 | 18.24 USD |
| 7/21/2026 | 17.92 USD |
| 7/20/2026 | 17.18 USD |
| 7/17/2026 | 17.52 USD |
| 7/16/2026 | 17.33 USD |
| 7/15/2026 | 18.51 USD |
| 7/14/2026 | 18.63 USD |
| 7/13/2026 | 17.85 USD |
| 7/10/2026 | 17.81 USD |
| 7/9/2026 | 17.39 USD |
| 7/8/2026 | 18.95 USD |
| 7/7/2026 | 18.85 USD |
| 7/6/2026 | 18.35 USD |
| 7/2/2026 | 19.01 USD |
| 7/1/2026 | 20.14 USD |
| 6/30/2026 | 20.52 USD |
| 6/29/2026 | 19.60 USD |
| 6/26/2026 | 20.74 USD |
| 6/25/2026 | 21.36 USD |
| 6/24/2026 | 21.17 USD |
| 6/23/2026 | 19.96 USD |
| 6/22/2026 | 21.28 USD |
| 6/18/2026 | 21.77 USD |
| 6/17/2026 | 22.84 USD |
| 6/16/2026 | 21.82 USD |
| 6/15/2026 | 22.54 USD |
| 6/12/2026 | 22.24 USD |
| 6/11/2026 | 21.01 USD |
| 6/10/2026 | 20.13 USD |
| 6/9/2026 | 20.22 USD |
| 6/8/2026 | 20.86 USD |
| 6/5/2026 | 21.06 USD |
| 6/4/2026 | 21.44 USD |
| 6/3/2026 | 23.13 USD |
| 6/2/2026 | 23.93 USD |
| 6/1/2026 | 21.66 USD |
| 5/29/2026 | 22.38 USD |
| 5/28/2026 | 22.80 USD |
| 5/27/2026 | 22.13 USD |
| 5/26/2026 | 21.76 USD |
| 5/22/2026 | 21.27 USD |
| 5/21/2026 | 21.07 USD |
| 5/20/2026 | 22.27 USD |
| 5/19/2026 | 21.75 USD |
| 5/18/2026 | 22.94 USD |
| 5/15/2026 | 23.13 USD |
| 5/14/2026 | 24.86 USD |
| 5/13/2026 | 25.18 USD |
| 5/12/2026 | 24.67 USD |
| 5/11/2026 | 25.26 USD |
| 5/8/2026 | 23.04 USD |
| 5/7/2026 | 22.41 USD |
| 5/6/2026 | 23.67 USD |
| 5/5/2026 | 27.94 USD |
| 5/4/2026 | 27.22 USD |
| 5/1/2026 | 27.73 USD |
| 4/30/2026 | 26.95 USD |
| 4/29/2026 | 26.34 USD |
| 4/28/2026 | 25.70 USD |
| 4/27/2026 | 26.48 USD |
| 4/24/2026 | 26.61 USD |
| 4/23/2026 | 24.19 USD |
| 4/22/2026 | 24.04 USD |
| 4/21/2026 | 23.72 USD |
| 4/20/2026 | 23.32 USD |
| 4/17/2026 | 23.18 USD |
| 4/16/2026 | 23.87 USD |
| 4/15/2026 | 23.03 USD |
| 4/14/2026 | 22.89 USD |
| 4/13/2026 | 23.05 USD |
| 4/10/2026 | 22.71 USD |
| 4/9/2026 | 21.84 USD |
| 4/8/2026 | 21.43 USD |
| 4/7/2026 | 22.34 USD |
| 4/6/2026 | 21.70 USD |
| 4/2/2026 | 21.55 USD |
| 4/1/2026 | 21.52 USD |
| 3/31/2026 | 22.03 USD |
| 3/30/2026 | 21.20 USD |
| 3/27/2026 | 21.60 USD |
| 3/26/2026 | 21.58 USD |
| 3/25/2026 | 20.77 USD |
| 3/24/2026 | 20.37 USD |
| 3/23/2026 | 18.50 USD |
| 3/20/2026 | 17.70 USD |
| 3/19/2026 | 18.94 USD |
| 3/18/2026 | 19.02 USD |
| 3/17/2026 | 18.99 USD |
| 3/16/2026 | 17.64 USD |
| 3/13/2026 | 17.57 USD |
| 3/12/2026 | 17.70 USD |
| 3/11/2026 | 17.89 USD |
| 3/10/2026 | 17.80 USD |
| 3/9/2026 | 17.42 USD |
| 3/6/2026 | 16.41 USD |
| 3/5/2026 | 16.75 USD |
| 3/4/2026 | 17.53 USD |
| 3/3/2026 | 16.77 USD |
| 3/2/2026 | 17.99 USD |
| 2/27/2026 | 18.24 USD |
| 2/26/2026 | 17.32 USD |
| 2/25/2026 | 18.02 USD |
| 2/24/2026 | 18.41 USD |
| 2/23/2026 | 18.03 USD |
| 2/20/2026 | 17.04 USD |
| 2/19/2026 | 20.41 USD |
| 2/18/2026 | 21.15 USD |
| 2/17/2026 | 20.68 USD |
| 2/13/2026 | 20.52 USD |
| 2/12/2026 | 20.42 USD |
| 2/11/2026 | 21.02 USD |
| 2/10/2026 | 19.25 USD |
| 2/9/2026 | 18.93 USD |
| 2/6/2026 | 18.32 USD |
| 2/5/2026 | 16.89 USD |
| 2/4/2026 | 17.94 USD |
| 2/3/2026 | 16.52 USD |
| 2/2/2026 | 15.58 USD |
| 1/30/2026 | 14.99 USD |
| 1/29/2026 | 15.24 USD |
| 1/28/2026 | 15.11 USD |
| 1/27/2026 | 15.63 USD |
| 1/26/2026 | 15.80 USD |
| 1/23/2026 | 15.75 USD |
| 1/22/2026 | 16.04 USD |
| 1/21/2026 | 16.19 USD |
| 1/20/2026 | 15.26 USD |
| 1/16/2026 | 15.61 USD |
| 1/15/2026 | 15.56 USD |
| 1/14/2026 | 14.96 USD |
| 1/13/2026 | 14.69 USD |
| 1/12/2026 | 14.72 USD |
| 1/9/2026 | 14.30 USD |
| 1/8/2026 | 13.85 USD |
| 1/7/2026 | 13.07 USD |
| 1/6/2026 | 13.28 USD |
| 1/5/2026 | 12.74 USD |
| 1/2/2026 | 12.25 USD |
| 12/31/2025 | 11.79 USD |
| 12/30/2025 | 11.82 USD |
| 12/29/2025 | 11.96 USD |
| 12/26/2025 | 12.09 USD |
| 12/24/2025 | 12.00 USD |
| 12/23/2025 | 11.74 USD |
| 12/22/2025 | 12.00 USD |
| 12/19/2025 | 11.82 USD |
| 12/18/2025 | 11.87 USD |
| 12/17/2025 | 11.61 USD |
| 12/16/2025 | 11.69 USD |
| 12/15/2025 | 11.78 USD |
| 12/12/2025 | 12.95 USD |
| 12/11/2025 | 13.15 USD |
| 12/10/2025 | 13.06 USD |
| 12/9/2025 | 12.40 USD |
| 12/8/2025 | 12.20 USD |
| 12/5/2025 | 12.70 USD |
| 12/4/2025 | 12.54 USD |
| 12/3/2025 | 12.96 USD |
| 12/2/2025 | 12.77 USD |
| 12/1/2025 | 12.84 USD |
| 11/28/2025 | 12.79 USD |
| 11/26/2025 | 12.47 USD |
| 11/25/2025 | 12.32 USD |
| 11/24/2025 | 11.50 USD |
| 11/21/2025 | 11.05 USD |
| 11/20/2025 | 10.48 USD |
| 11/19/2025 | 10.70 USD |
| 11/18/2025 | 10.93 USD |
| 11/17/2025 | 11.25 USD |
| 11/14/2025 | 11.89 USD |
| 11/13/2025 | 12.27 USD |
| 11/12/2025 | 12.61 USD |
| 11/11/2025 | 12.65 USD |
| 11/10/2025 | 12.75 USD |
| 11/7/2025 | 12.51 USD |
| 11/6/2025 | 11.74 USD |
| 11/5/2025 | 12.05 USD |
| 11/4/2025 | 12.21 USD |
| 11/3/2025 | 12.68 USD |
| 10/31/2025 | 13.39 USD |
| 10/30/2025 | 13.12 USD |
| 10/29/2025 | 13.76 USD |
| 10/28/2025 | 13.85 USD |
| 10/27/2025 | 14.00 USD |
| 10/24/2025 | 14.05 USD |
| 10/23/2025 | 13.88 USD |
| 10/22/2025 | 13.52 USD |
| 10/21/2025 | 13.36 USD |
| 10/20/2025 | 13.31 USD |
| 10/17/2025 | 12.90 USD |
| 10/16/2025 | 13.76 USD |
| 10/15/2025 | 14.42 USD |
| 10/14/2025 | 13.76 USD |
| 10/13/2025 | 13.44 USD |
| 10/10/2025 | 12.55 USD |
| 10/9/2025 | 13.74 USD |
| 10/8/2025 | 15.04 USD |
| 10/7/2025 | 15.09 USD |
| 10/6/2025 | 15.80 USD |
| 10/3/2025 | 16.13 USD |
| 10/2/2025 | 16.34 USD |
| 10/1/2025 | 15.91 USD |
| 9/30/2025 | 15.84 USD |
| 9/29/2025 | 15.60 USD |
| 9/26/2025 | 15.66 USD |
| 9/25/2025 | 15.33 USD |
| 9/24/2025 | 16.36 USD |
| 9/23/2025 | 16.49 USD |
| 9/22/2025 | 17.02 USD |
| 9/19/2025 | 17.01 USD |
| 9/18/2025 | 17.53 USD |
| 9/17/2025 | 17.17 USD |
| 9/16/2025 | 17.08 USD |
| 9/15/2025 | 17.26 USD |
| 9/12/2025 | 16.75 USD |
| 9/11/2025 | 16.76 USD |
| 9/10/2025 | 16.28 USD |
| 9/9/2025 | 16.67 USD |
| 9/8/2025 | 16.25 USD |
| 9/5/2025 | 15.66 USD |
| 9/4/2025 | 15.09 USD |
| 9/3/2025 | 14.98 USD |
| 9/2/2025 | 15.32 USD |
| 8/29/2025 | 15.40 USD |
| 8/28/2025 | 15.07 USD |
| 8/27/2025 | 15.23 USD |
| 8/26/2025 | 15.19 USD |
Chemours Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEB USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.86 | 6.43 | 5.72 | 5.40 | 6.18 | 6.64 | 5.53 | 4.97 | 6.35 | 6.83 | 6.08 | 5.78 | 5.81 | 5.94 | 6.23 | 6.48 |
| -6.87 | -6.23 | -11.12 | -5.54 | 14.50 | 7.36 | -16.75 | -10.08 | 27.69 | 7.66 | -11.02 | -4.87 | 0.45 | 2.22 | 4.90 | 4.11 |
| 21.34 | 21.14 | 16.70 | 20.56 | 28.37 | 29.69 | 19.24 | 21.47 | 21.77 | 23.66 | 21.49 | 19.91 | 15.53 | 15.53 | 15.53 | 15.53 |
| 1.46 | 1.36 | 0.96 | 1.11 | 1.75 | 1.97 | 1.06 | 1.07 | 1.38 | 1.62 | 1.31 | 1.15 | 0.90 | 0.92 | 0.97 | 1.01 |
| 0.53 | 0.53 | 0.23 | 0.10 | 1.07 | 1.23 | 0.45 | 0.45 | 0.86 | 0.79 | -0.11 | 0.44 | -0.01 | 0.38 | 0.39 | 0.41 |
| 7.76 | 8.27 | 3.95 | 1.78 | 17.34 | 18.56 | 8.09 | 9.02 | 13.54 | 11.51 | -1.81 | 7.66 | -0.09 | 6.32 | 6.31 | 6.32 |
| 0.42 | 0.40 | -0.09 | 0.01 | 0.75 | 1.00 | -0.05 | 0.22 | 0.61 | 0.58 | -0.24 | 0.09 | -0.39 | 0.16 | 0.29 | 0.35 |
| -59.98 | -5.44 | -122.50 | -107.78 | 10,557.14 | 33.38 | -105.23 | -521.15 | 177.63 | -4.93 | -141.18 | -136.13 | -548.84 | -140.93 | 86.08 | 19.05 |
| – | – | 0.81 | 0.12 | 0.12 | 0.89 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.51 | 0.35 | 0.35 | 0.35 |
| – | – | – | -85.19 | – | 641.67 | 12.36 | – | – | – | – | – | -49.00 | -31.37 | – | – |
| 181.37 | 181.37 | 180.97 | 186.04 | 182.07 | 167.87 | 164.25 | 164.76 | 168.95 | 150.05 | 148.59 | 149.83 | 150.55 | 150.55 | 150.55 | 150.55 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Chemours generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Chemours retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Chemours's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Chemours has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Chemours's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Chemours stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours business model & stock analysis
Chemours Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours Segments
Chemours Revenue by Segment (1/6)
3 Years
5 Years
Max
Details
Chemours Revenue by Segment (2/6)
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours Revenue by Segment (3/6)
3 Years
5 Years
Max
Details
Chemours Revenue by Segment (4/6)
3 Years
5 Years
10 Years
Max
Details
Chemours Revenue by Segment (5/6)
Max
Details
Chemours Revenue by Segment (6/6)
Max
Details
Chemours Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Chemours Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Chemours historical P/E ratio, EBIT multiple, and P/S ratio
Chemours annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Chemours shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemours Dividend History
12 years of dividend payments
Chemours dividend history and estimates
Max
Details
Chemours dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Chemours forecasts and price targets in August 2026
Analyst Price Targets 2026Chemours Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/13/2026 | Maintained | Neutral | 61 | |
| 8/13/2026 | Maintained | Outperform | 62 | |
| 8/10/2026 | Downgrade | BuyNeutral | 50 | |
| 8/6/2026 | Maintained | Buy | – | |
| 8/6/2026 | Maintained | Outperform | 48 | |
| 7/1/2026 | Maintained | Outperform | 31 | |
| 5/21/2026 | Maintained | Neutral | 61 | |
| 5/11/2026 | Maintained | Outperform | 48 | |
| 5/11/2026 | Maintained | Equal Weight | 51 | |
| 5/8/2026 | Maintained | Buy | 50 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Chemours Earnings Calls
Chemours Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/3/2026 | 0.43USD | - | 1.70 BUSD | - | 2026 Q2 |
| 5/5/2026 | -0.05USD | - | 1.43 BUSD | - | 2026 Q1 |
| 2/19/2026 | 0.07USD | - | 1.37 BUSD | - | 2025 Q4 |
| 4/25/2024 | 0.89USD | - | 1.62 BUSD | - | 2024 Q1 |
| 2/7/2024 | 0.23USD | - | 1.35 BUSD | - | 2023 Q4 |
| 7/26/2023 | 1.34USD | - | 1.67 BUSD | - | 2023 Q2 |
| 5/1/2023 | 0.73USD | - | 1.47 BUSD | - | 2023 Q1 |
| 2/8/2023 | 0.33USD | - | 1.35 BUSD | - | 2022 Q4 |
| 10/25/2022 | 1.07USD | - | 1.70 BUSD | - | 2022 Q3 |
| 7/28/2022 | 1.48USD | - | 1.86 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Chemours stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Chemours shareholder structure
| % | Name |
|---|---|
15.87975% | |
14.90035% | |
11.90546% | |
6.87270% | |
4.50882% | |
4.08573% |
Chemours Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
14.30% | SEC ↗ | |
12.00% | SEC ↗ | |
12.00% | SEC ↗ | |
12.00% | SEC ↗ | |
11.30% | SEC ↗ | |
10.97% | SEC ↗ | |
9.98% | SEC ↗ | |
6.96% | SEC ↗ | |
5.26% | SEC ↗ | |
5.10% | SEC ↗ |
Chemours Executives and Management Board
18 members · avg. age 57 · 44 % women
Ms. Denise Dignam (59)
President, Chief Executive Officer, Director · since 2021
5.89 M USD
Management
Ms. Kristine Wellman (55)
Senior Vice President, General Counsel, Corporate Secretary
Mr. Joseph Martinko (57)
President - Thermal and Specialized Solutions
Mr. Gerardo Calderon (49)
President - Advanced Performance Materials
Mr. Shane Hostetter (43)
Chief Financial Officer
Ms. Alvenia Scarborough (51)
Senior Vice President - Corporate Communications and Chief Brand Officer
Mr. Damian Gumpel (50)
President - Chemours Titanium Technologies
Board of Directors
Ms. Pamela Fletcher (58)
Independent Director
Ms. Mary Cranston (77)
Independent Chair of the Board
Ms. Erin Kane (48)
Independent Director
Mr. Sean Keohane (57)
Independent Director
Mr. Alister Cowan (60)
Lead Independent Director
Mr. Livingston Satterthwaite (64)
Independent Director
Frequently asked questions about Chemours
The business model of Chemours Co is centered around the production and sale of performance chemicals. Chemours specializes in areas such as titanium technologies, fluoroproducts, and chemical solutions. With a strong focus on innovation and sustainability, the company strives to provide solutions that fulfill market needs while minimizing environmental impact. Chemours leverages its expertise to develop and supply high-quality products across various industries, including automotive, electronics, and construction. By continually refining its products and processes, Chemours aims to create value for its customers and shareholders, maintaining a robust presence in the global chemical industry.
Chemours Co is primarily active in the chemical manufacturing industry. They specialize in the production of performance chemicals used in various sectors such as automotive, electronics, construction, and industrial applications. With a focus on innovative solutions, Chemours Co aims to provide high-quality products that cater to the unique needs of different industries. As a global leader in the chemicals market, Chemours Co continues to drive advancements and contribute to the growth and sustainability of industries worldwide.
The main competitors of Chemours Co in the market include The Chemours Company, which is a global leader in titanium technologies, fluoroproducts, and chemical solutions. Additionally, other notable competitors in the industry include DuPont, a multinational conglomerate that also specializes in chemicals, materials, and energy, as well as BASF SE, a German chemical company and the largest chemical producer worldwide. These competitors engage in intense market competition, driving innovation and ensuring a diverse range of products and solutions for customers in various industries.
Chemours Co, previously a part of DuPont, is a leading global provider of performance chemicals. Founded in 2015, Chemours specializes in delivering innovative solutions across various industries such as automotive, electronics, coatings, and energy. With a strong commitment to sustainable practices, the company focuses on developing products that address societal challenges while minimizing environmental impact. Chemours has a rich heritage and expertise spanning over two centuries, inheriting DuPont's legacy in chemical innovation. As an independent company, Chemours continues to build on its strong foundation, driving growth and providing value to its customers through a diverse portfolio of high-quality products and solutions.
Chemours Co has achieved several significant milestones since its inception. One notable achievement for the company was its successful spin-off from DuPont in 2015, making it an independent entity. Additionally, Chemours has made substantial progress in sustainable manufacturing practices, earning recognition for its commitment to reducing environmental impact. The company has also demonstrated a strong focus on innovation, introducing innovative products and technologies to their portfolio. Furthermore, Chemours has prioritized customer satisfaction by consistently delivering high-quality products and services. Through these achievements, Chemours Co has solidified its position as a leading player in the chemical industry.
Chemours Co is primarily present in various countries and regions around the world. The company has a global presence, with operations and offices in North America, Europe, Asia Pacific, and Latin America. Chemours Co serves customers in industries such as automotive, electronics, chemicals, and many more across these regions. With its strong international footprint, Chemours Co is committed to delivering innovative solutions and products to meet the diverse needs of customers worldwide.
Chemours Co represents a strong set of values and corporate philosophy. The company emphasizes integrity, innovation, and sustainability in all its operations. Chemours is committed to delivering exceptional value to its customers, shareholders, and employees while maintaining a focus on responsible and ethical business practices. The company strives to provide innovative solutions that address global challenges and support a more sustainable future. Chemours believes in fostering a diverse and inclusive work environment that encourages collaboration, creativity, and continuous improvement. With its dedication to excellence, Chemours Co aims to be a leader in its industry and contribute positively to society.
Analysts currently set an average price target of 19.00 USD for the Chemours stock (median: 18.36 USD), implying +23.8 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the Chemours stock: 12 recommend buying, 5 holding and 1 selling. For 2026, analysts expect Chemours to generate revenue of 5.94 B USD and earnings per share of 1.06 USD.
Converted at the current exchange rate, the Chemours share trades at 13.15 EUR (15.35 USD).
The Chemours share (CC) is listed on 8 stock exchanges, including: NYSE (CC), XETRA (2CU.DE), Frankfurt (2CU.F), München (2CU.MU), Düsseldorf (2CU.DU), London (0HWG.L), London (0HWG.L), SIX (Zürich) (2CU.SW).
Chemours Co is a US-American corporation that was separated from the chemical company DuPont in 2015. The company specializes in the production of chemicals and materials and offers its products and services worldwide. The business model of Chemours Co is based on three different business segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacturing and distribution of titanium dioxide, which is mainly used in the production of paints, coatings, paper, and plastics. The product range includes standard titanium dioxide, processed titanium dioxide, and specially treated products. The company is one of the largest providers of titanium dioxide worldwide and is often engaged in negotiations with customers, suppliers, and competitors to ensure price and production capacity. The Fluoroproducts segment specializes in the production and distribution of fluorocarbons, including refrigerants, fire extinguishing agents, and chemicals for coatings. The brand "Teflon" plays an important role in this segment, known for its special coatings and non-stick properties. The company also conducts research and development to develop new fluorochemicals as there is strong competitive pressure in this market. The Chemical Solutions segment offers chemicals and equipment for various applications, such as water treatment or the oil and gas industry. The focus is on products used in the production of cooling and lubricating agents, as well as catalysts. Another important aspect of Chemours Co's business model is the production of HFC-23 (used in refrigerators and air conditioners), which emerged based on the reduction commitments from the Kyoto Protocol. Overall, the three business segments of Chemours Co complement each other well and offer a wide range of products. The close collaboration between research and development, sales, and production plays an important role in ensuring that the company's products are always state-of-the-art. Sustainability is also an integral part of Chemours Co's business model. The company is committed to efficient and sustainable production of its products and strives for comprehensive transparency of its processes. Furthermore, the company aims to eliminate the use of perfluorooctanesulfonic acid (PFOS) in some applications of Teflon products. Overall, Chemours Co's business model is focused on long-term and sustainable development, based on access to resources and energy, the discovery of innovations, and strict adherence to ecological and social conditions.
The expected revenue of Chemours is 5.94 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Chemours is 158.94 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Chemours is currently 14.54. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Chemours stock.
The price-to-sales ratio (P/S) of Chemours is currently 0.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Chemours stock.
The Eulerpool Quality Score for Chemours is 1/10.
The ISIN of Chemours is US1638511089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Chemours is A14RPH. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Chemours is CC. The ticker symbol is used to trade Chemours shares on the stock exchange.
Over the past 12 months, Chemours paid a dividend of 0.51 USD . This corresponds to a dividend yield of about 3.34 %. For the coming 12 months, Chemours is expected to pay a dividend of 0.35 USD.
The current dividend yield of Chemours is 3.34 %.
Chemours pays a dividend, distributed in the months of , , , .
Chemours paid dividends every year for the past 11 years.
For the upcoming 12 months, dividends amounting to 0.35 USD are expected. This corresponds to a dividend yield of 2.28 %.
Chemours is assigned to the 'Commodities' sector.
To receive the latest dividend of Chemours from amounting to 0.09 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Chemours distributed 1 USD as dividends.
The dividends of Chemours are distributed in USD.
Chemours stock
Chemours Peer Group
Chemours Ticker
Chemours FIGI
All fundamentals and in-depth analysis of Chemours
Our stock analysis for Chemours stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemours. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.